Related Experiment Video
Updated: Jul 15, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
The iron woman: a case report of contemporary cardiac support
Jeremy A Brooksbank1, Nikolaos Spilias2, Carmela D Tan3
1TriStar Centennial Medical Center, Advanced Heart Failure and Transplant Cardiology, 2400 Patterson St. Suite 502, Nashville, TN 37203, USA.
Insights
This case study details a patient with heart failure with reduced ejection fraction and severe mitral regurgitation who underwent multiple device therapies. It highlights the progression of advanced heart failure treatments, including mechanical support and cardiac transplantation.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Heart Failure Management
Background:
- Modern cardiovascular practice employs diverse devices and procedures for functional and structural heart disease.
- Heart failure with reduced ejection fraction (HFrEF) and mitral regurgitation are common clinical challenges.
Observation:
- A female patient with HFrEF and severe mitral regurgitation received a comprehensive suite of device-based therapies.
- Therapies included mitral transcatheter edge-to-edge repair, percutaneous mitral annuloplasty (Carillon device), temporary mechanical circulatory support, and a durable left ventricular assist device.
Findings:
- The patient ultimately required cardiac transplantation following the failure of other interventions.
- This case illustrates a stepwise progression through advanced heart failure management strategies.
Implications:
- Understanding the indications and data for various device therapies is crucial for managing complex heart failure.
- This case underscores the potential need for escalating mechanical circulatory support and transplantation in refractory cases.
Background:
Modern cardiovascular practice utilizes various devices and procedures to treat functional and structural heart disease.
Case Summary:
We report an interesting case of a female patient with heart failure with reduced ejection fraction (HFrEF) and severe mitral regurgitation who received the full spectrum of available device-based therapies including mitral transcatheter edge-to-edge repair, percutaneous mitral annuloplasty with the Carillon device, temporary mechanical circulatory support, durable left ventricular assist device, and eventually cardiac transplantation.
Discussion:
Management of HFrEF and functional mitral regurgitation is a common clinical issue for which numerous devices may be utilized to improve patient symptoms and outcomes. In this report, we review indications, supporting data, and anatomical relationships of some of these devices. We also highlight stepwise progression to advanced heart failure requiring temporary and durable mechanical circulatory support followed ultimately by heart transplantation.
More Related Videos
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Introduction Cardiac Emergencies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management